Google & Flo Health Launch Wearable Femtech Partnership

Google has announced its latest strategic partnership, which will see the global technology giant collaborate with leading women’s health platform Flo Health to integrate the Flo app into Google’s wearable technology. 

With more than 80 million monthly users, the Flo app offers in-depth menstrual cycle tracking enhanced by AI and data-backed predictions.

From early 2027, consenting users will have the ability to connect Flo with Google Fitbit, the company’s wearable health platform. 

“By teaming up with Flo, together with our personalised coaching, research expertise and 24/7 tracking, we can help women understand their health in entirely new ways,” says Rishi Chandra, Vice President and General Manager of Google Health.

The multi-year partnership accompanies Google’s strategic investment in Flo Health. The companies have outlined plans for future collaborative research into women’s healthcare, aiming to produce new insights into hormonal symptoms and chronic conditions. 

Menstrual cycle data meets biometric technology

Launched in 2015, Flo was initiated as a period-tracking calendar. Development has brought in a wider range of features, offering users broader healthcare support.

In 2024, Flo became the first femtech unicorn after raising US$200m in financing from US-based equity firm General Atlantic. 

“Over a decade ago, we set out to build technology that truly understands women’s bodies,” reflects Dmitry Gurski, CEO of Flo Health, on LinkedIn. “Today, half a billion people have downloaded Flo.”

Since 2025, Flo has utilised AI pilots produced by data intelligence provider Databricks to manage its data systems.

“This partnership is a recognition of the trust women have placed in us, and a chance to do so much more for women’s health,” Dmitry continues, adding that the partnership “will put women’s health at the centre of wearable fitness tracking.”

Once the platform integrates with Google’s wearable health technology, users will be able to combine signals recorded by the wearable Fitbit device with cycle data drawn from Flo. The companies hope that combining a broader range of data will refine predictions and further personalise health guidance.

Additionally, users will be able to monitor insights from Flo directly in the Google Health app. 

“This is a recognition of the vital importance of women’s health and the need to bring dedicated experiences and tools to life that can better support them,” says Dmitry.

The partnership aligns with Google’s wider strategy to synchronise information from multiple health services into its Fitbit platform. Its expanding network of partnerships includes Abbott’s glucose monitor Lingo, MyFitnessPal’s nutrition tracking platform and Function Health’s laboratory results manager. 

The trend reflects a shift toward increasingly personalised digital health platforms that offer long-term guidance and reflect a broader picture of a user’s health.

A research partnership: advancing femtech

The research disparity in women’s health is long-recorded. Google and Flo’s partnership presents a route for women to gain a deeper understanding of their hormonal health and its broader effects.

Beyond integrating the two platforms, Google and Flo have established intentions to develop a new line of femtech products. Harnessing Flo’s knowledge database, the companies intend to produce wearable solutions designed to aid women’s personal health management.

For women living with under-researched chronic conditions like endometriosis and polycystic ovary syndrome (PCOS), the new early symptom detection systems proposed by the companies could offer significant support. 

A key concern as the partnership moves forward stems from the existing women’s health research deficit. 

The companies intend to use AI to enhance their future product line. However, inaccurate information and medical dataset gaps pose a clear risk to products based on machine learning.

To mitigate this risk, the companies will launch a joint research programme,  committing to closing the research gap. Together, they aim to develop AI models backed by a more precise understanding of female hormones.

“AI is about to change what is possible in women's health,” Dmitry says: “but only if it's built with women in mind, not adapted for them afterward.”

Key partners for Google Health

Function Health

CEO: Jonathan Swerdlin | HQ: Austin, Texas

Function Health is a preventive health platform offering access to laboratory testing and health insights. Its service focuses on helping members understand biomarkers through testing and longitudinal health information. Google Health has announced plans to let users in the US import clinical laboratory results from Function Health into the Google Health app, extending its connected health data offering.

Dexcom

CEO: Jake Leach | HQ: San Diego, California

Dexcom designs and manufactures continuous glucose monitoring (CGM) systems for ambulatory digital health management. The company collaborates across the Google Health software ecosystem to combine metabolic tracking with broader lifestyle metrics, reflecting the industry's shift toward integrated multi-sensor chronic condition and wellness management platforms.

Abbott 

CEO: Robert B Ford | HQ: Abbott Park, Illinois 

Abbott is a global healthcare company operating across medical devices, diagnostics, nutrition and pharmaceuticals. Its consumer health portfolio includes Lingo, a continuous glucose monitoring system designed to help users understand their glucose patterns. Through its integration with Google Health in August 2026, US-based users can connect Lingo data with the Google Health app, bringing their glucose records together with wider health metrics to provide a more connected view of wellbeing.